<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 19.4: Mechanisms of Musculoskeletal Longevity</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Research & Evidence */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs & Highlights */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            text-align: center;
        }

        .stat-number {
            font-size: 38px;
            font-weight: 700;
            margin-bottom: 8px;
            display: block;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f1f5f9;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fafafa;
            border-radius: 12px;
            font-size: 14px;
            color: #666;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #333;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 50px;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .stats-grid { grid-template-columns: 1fr 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 19: L2: Research & Evidence</p>
            <h1 class="lesson-title">Lesson 4: Mechanisms of Musculoskeletal Longevity</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 4 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>VO2 Max & Mortality Dose-Response</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Molecular Biology of Exercise</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Sarcopenia vs. Dynapenia</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Autophagy Induction Pathways</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Bone Mineral Density (BMD)</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Application Protocols</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the landmark cohort data linking cardiorespiratory fitness to all-cause mortality.</li>
                <li>Identify the specific myokines and molecular signals (PGC-1Î±) activated by resistance training.</li>
                <li>Differentiate between the hazard ratios of muscle mass loss versus muscle strength loss.</li>
                <li>Evaluate the mechanisms of exercise-induced autophagy (HIIT vs. Zone 2).</li>
                <li>Determine the predictive value of BMD in longevity and post-fracture survival rates.</li>
            </ul>
        </div>

        <p>While previous lessons in this module focused on the systemic evidence of epigenetic clocks and the microbiome, we now turn our attention to the most visible and mechanically vital pillar of the <strong>A.G.E.L.E.S.S. Longevity Protocolâ„¢</strong>: Exercise ('E'). The musculoskeletal system is not merely for locomotion; it is an endocrine organ and the primary reservoir for metabolic health. In this lesson, we dissect the high-level research that establishes musculoskeletal integrity as the ultimate predictor of biological youth.</p>

        <h2 id="section1">1. VO2 Max and All-Cause Mortality: The Gold Standard</h2>
        <p>In the hierarchy of longevity biomarkers, <span class="highlight">VO2 Max</span> (maximal oxygen consumption) stands as the single most powerful predictor of how long a human will live. While many practitioners focus on cholesterol or blood pressure, the research suggests that cardiorespiratory fitness (CRF) provides a far more significant risk-reduction profile.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">5x</span>
                    <span class="stat-label">Higher Mortality Risk</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">n=122k</span>
                    <span class="stat-label">Study Participants</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">0.20</span>
                    <span class="stat-label">Hazard Ratio (Elite)</span>
                </div>
            </div>
            <p style="margin-top: 20px; font-size: 14px; text-align: center; opacity: 0.9;">A 2018 study by <strong>Mandsager et al.</strong> published in <i>JAMA Network Open</i> found that the risk of death for the lowest fitness group was 5 times higher than the elite groupâ€”a risk greater than smoking or end-stage renal disease.</p>
        </div>

        <p>The dose-response relationship is linear and shows no upper limit of benefit. Moving from the "Below Average" category to "Above Average" results in a <span class="highlight">60-70% reduction in all-cause mortality</span>. Even more striking is that the jump from "Lowest" to "Below Average" provides the single greatest return on investment, emphasizing that for your clients, "some is significantly better than none."</p>

        <h2 id="section2">2. Molecular Biology of 'E': Myokines and Biogenesis</h2>
        <p>When we apply the 'E' pillar of the A.G.E.L.E.S.S. Protocolâ„¢, we are triggering a cascade of molecular events. Muscle is an endocrine organ that secretes <span class="highlight">myokines</span>â€”signaling proteins that communicate with the brain, liver, and adipose tissue.</p>

        <div class="principle-card">
            <div class="principle-title">Key Molecular Players</div>
            <ul class="content-list">
                <li><strong>PGC-1Î±:</strong> The "master regulator" of mitochondrial biogenesis. It coordinates the expression of genes that increase the number and efficiency of mitochondria.</li>
                <li><strong>Irisin:</strong> Released during muscle contraction; it promotes the "browning" of white adipose tissue, increasing thermogenesis and metabolic rate.</li>
                <li><strong>IL-6 (Interleukin-6):</strong> Unlike the pro-inflammatory IL-6 from the immune system, exercise-induced IL-6 acts as an anti-inflammatory, sensitizing the body to insulin and suppressing TNF-alpha.</li>
            </ul>
        </div>

        <p>Resistance training specifically modulates the <strong>mTOR/AMPK axis</strong>. While we often discuss mTOR in the context of growth (and sometimes its inhibition for longevity), pulsatile activation of mTOR through mechanical loading is essential for maintaining the <span class="highlight">satellite cell pool</span>â€”the stem cells of our muscles that decline with age.</p>

        <h2 id="section3">3. Sarcopenia vs. Dynapenia: Mass vs. Strength</h2>
        <p>It is a common clinical error to focus solely on muscle mass (Sarcopenia). However, the evidence is shifting toward <span class="highlight">Dynapenia</span>â€”the age-associated loss of muscle strength that is not caused by neurologic or muscular diseases.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Metric</th>
                        <th>Sarcopenia (Mass)</th>
                        <th>Dynapenia (Strength)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Primary Biomarker</strong></td>
                        <td>ALM (Appendicular Lean Mass) via DXA</td>
                        <td>Grip Strength / Leg Press 1RM</td>
                    </tr>
                    <tr>
                        <td><strong>Mortality Hazard Ratio</strong></td>
                        <td>~1.2 - 1.5 (Moderate risk)</td>
                        <td>~1.8 - 2.5 (High risk)</td>
                    </tr>
                    <tr>
                        <td><strong>Functional Outcome</strong></td>
                        <td>Metabolic Buffer / Glycemic Control</td>
                        <td>Fall Prevention / Power Output</td>
                    </tr>
                    <tr>
                        <td><strong>Intervention Priority</strong></td>
                        <td>Protein Intake + Hypertrophy</td>
                        <td>Neuromuscular Training + Explosive Power</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>A meta-analysis of 42 studies involving over 3 million participants found that <strong>low grip strength</strong> was a stronger predictor of all-cause and cardiovascular mortality than systolic blood pressure. This highlights why the <i>Assess</i> ('A') phase of our protocol must include functional strength testing, not just body composition scans.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Skinny Fat" Longevity Paradox</p>
                    <p class="subtitle">Client: Arthur, Age 72</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">A</div>
                    <div class="patient-info">
                        <h4>Arthur M.</h4>
                        <p>Normal BMI (24.1), but low grip strength (22kg) and low VO2 Max (24 ml/kg/min).</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Arthur was initially focused on calorie restriction for "longevity." Using the A.G.E.L.E.S.S. Protocolâ„¢, we pivoted him to <strong>high-intensity resistance training</strong> (2x/week) and <strong>Zone 2 base building</strong> (3x/week), alongside increasing protein to 1.6g/kg.</p>
                <p><strong>Outcome:</strong> After 6 months, Arthur's grip strength increased to 34kg (moving him from the 10th to 50th percentile). Despite his weight remaining stable, his fasting insulin dropped by 40%, and his Biological Age (via PhenoAge) decreased by 3.4 years.</p>
            </div>
        </div>

        <h2 id="section4">4. Autophagy Induction: HIIT vs. Zone 2</h2>
        <p>Autophagyâ€”the cellular "self-cleaning" processâ€”is a hallmark of longevity. While fasting is the most discussed trigger, <span class="highlight">exercise-induced autophagy</span> is more tissue-specific and arguably more potent for musculoskeletal health.</p>

        <p><strong>Zone 2 (Aerobic Base):</strong> Training at the first lactate threshold primarily induces autophagy in the mitochondria (mitophagy). This clears out dysfunctional mitochondria and stimulates the production of new, efficient ones. This is a volume-dependent process, requiring 150-200 minutes per week for optimal longevity signaling.</p>

        <p><strong>HIIT (High Intensity):</strong> HIIT triggers a massive surge in <span class="highlight">AMPK</span>, which directly inhibits mTOR and activates the ULK1 complex, the initiator of autophagy. HIIT is particularly effective at clearing misfolded proteins within the sarcoplasm of the muscle fibers. Research suggests that just 2-3 HIIT sessions per week can significantly upregulate autophagy markers in skeletal muscle that remain elevated for up to 24 hours.</p>

        <h2 id="section5">5. Bone Mineral Density (BMD) as a Mortality Predictor</h2>
        <p>We cannot discuss musculoskeletal longevity without bone. In the longevity community, BMD is often overlooked in favor of muscle, yet the data on <span class="highlight">hip fractures</span> is sobering. A hip fracture in an individual over 65 is often a "sentinel event" that marks the beginning of rapid decline.</p>

        <div class="stats-box" style="background: linear-gradient(135deg, #8B0000 0%, #B22222 100%);">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">21-30%</span>
                    <span class="stat-label">1-Year Mortality Rate</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">50%</span>
                    <span class="stat-label">Loss of Independence</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">3x</span>
                    <span class="stat-label">Risk in Men vs Women</span>
                </div>
            </div>
            <p style="margin-top: 20px; font-size: 14px; text-align: center; opacity: 0.9;">Post-fracture mortality is not just due to the bone break, but the rapid "inflammaging" and muscle wasting (disuse atrophy) that follows hospitalization.</p>
        </div>

        <p>Research indicates that for every standard deviation decrease in BMD, the risk of all-cause mortality increases by 40%. This is likely because BMD serves as a proxy for long-term hormonal health, nutritional status, and physical activity levels throughout the lifespan.</p>

        <h2 id="section6">6. Clinical Application: The A.G.E.L.E.S.S. Protocolâ„¢ Integration</h2>
        <p>As a Longevity Coach, your role is to translate this research into a sustainable protocol. Based on the evidence reviewed, the "Minimum Effective Dose" for musculoskeletal longevity includes:</p>

        <div class="principle-card">
            <div class="principle-title">The 4-Pillar Movement Prescription</div>
            <ul>
                <li><strong>Strength (Dynapenia Mitigation):</strong> 2-3 sessions per week targeting major compound movements (squat, hinge, push, pull). Focus on mechanical tension.</li>
                <li><strong>Zone 2 (Mitochondrial Health):</strong> 150+ minutes per week at an intensity where the client can maintain a conversation but feels slight exertion.</li>
                <li><strong>Vigorous Intensity (VO2 Max):</strong> 1 session per week of "4x4" intervals (4 mins high intensity, 3 mins recovery) to push the aerobic ceiling.</li>
                <li><strong>Impact/Loading (BMD):</strong> Inclusion of weight-bearing exercises or plyometrics (if appropriate) to stimulate osteoblast activity.</li>
            </ul>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of musculoskeletal longevity research.</p>

            <div class="question-item">
                <p class="question-text">1. According to the Mandsager et al. (2018) study, how does the mortality risk of the lowest fitness group compare to the elite fitness group?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The lowest fitness group has a 5-fold (500%) higher risk of all-cause mortality compared to the elite group, making low cardiorespiratory fitness a greater risk factor than smoking or diabetes.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Which is a better predictor of mortality in the elderly: Muscle Mass (Sarcopenia) or Muscle Strength (Dynapenia)?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Muscle Strength (Dynapenia). Research shows that grip strength and leg power have significantly higher hazard ratios for mortality than muscle mass alone.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>VO2 Max is the King:</strong> It is the strongest modifiable predictor of longevity, with no observed "ceiling" for benefit.</li>
                <li><strong>Myokines are Medicine:</strong> Muscle contraction releases IL-6 and Irisin, which provide systemic anti-inflammatory and metabolic benefits.</li>
                <li><strong>Strength Over Size:</strong> Prioritize functional strength and power over mere hypertrophy for mortality risk reduction.</li>
                <li><strong>Fracture Prevention:</strong> BMD is a critical longevity biomarker; a hip fracture is a high-mortality event in the elderly.</li>
                <li><strong>Dual Pathway Autophagy:</strong> Use Zone 2 for mitophagy and HIIT for proteostasis (clearing misfolded proteins).</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <p>Mandsager et al. (2018). "Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing." <i>JAMA Network Open</i>.</p>
            <p>Kokkinos et al. (2022). "Cardiorespiratory Fitness and Mortality Risk Across the Continuum of Age in 750,302 Veterans." <i>Journal of the American College of Cardiology</i>.</p>
            <p>Pedersen et al. (2019). "The Physiology of Skeletal Muscle as an Endocrine Organ: Myokines in Health and Disease." <i>Nature Reviews Endocrinology</i>.</p>
            <p>McLeod et al. (2019). "The Role of Resistance Training in Attenuating Sarcopenia and Dynapenia." <i>Frontiers in Physiology</i>.</p>
            <p>He et al. (2012). "Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis." <i>Nature</i>.</p>
            <p>Bliuc et al. (2009). "Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women." <i>JAMA</i>.</p>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Longevity Certification Program</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Confidential Professional Certification Material.</p>
        </footer>
    </div>
</body>

</html>